The alarming rise in the worldwide prevalence of obesity is paralleled by an increasing
burden of type 2 diabetes mellitus. Metabolic surgery is the most effective means of …

Bariatric surgery is an effective therapy for obesity, hypertension and type 2 diabetes
mellitus that is refractory to maximal medical therapy. Results of long-term cohort studies …

Importance Early-stage chronic kidney disease (CKD) characterized by microalbuminuria is
associated with future cardiovascular events, progression toward end-stage renal disease …

Diabetes is a chronic disease that affects a vast number of individuals globally, and without
optimal treatment, can lead to significant health complications. Moreover, obesity is another …

Background We compared the albuminuria-lowering effects of Roux-en-Y gastric bypass
(RYGB) to best medical treatment in patients with diabetic kidney disease and obesity to …

Diabetic kidney disease (DKD) is one of the most common causes of end-stage renal
disease worldwide. The treatment of DKD is strongly associated with clinical outcomes in …

The global prevalence of overweight and obesity has risen substantially over the past 4
decades and is accompanied by an increasing burden of cardiovascular risk factors such as …

Abstract The 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and
International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated …

Introduction: Cardiovascular and renal disease accounts for a substantial proportion of the
morbidity and mortality associated with obesity and type 2 diabetes mellitus (T2DM) …

Obesity is a major factor in contemporary clinical practice in nephrology. Obesity accelerates
the progression of both diabetic and non-diabetic chronic kidney disease and, in renal …